A scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on January 4, 2024, in Esfahan’s
A scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on December 3, 2023, in Mashhad’s
Kimiara company organized a febuxostat advisory board meeting for the first time in Iran with the presence of rheumatology, nephrology and cardiology field veterans on
Kimiara company on saturday morning dated 1402/8/20 for a group of professors of the faculty of Shahid Beheshti University of Medical Sciences, Dr. Mohamadreza Minatur
Kimiara Company participated in the morning of Mofid Hospital in Tehran for the pediatric pulmonologists group on Saturday, August 19th2023. In this scientific meeting, which
Kimiara company participated in Amir Alam Hospital morning in Tehran for the group of otolaryngologists and face and neck surgeons on thursday, August 10th, 2023.
Participation of Kimiara company in the 7th International Iranian Heart Failure Summit on 9-11 August 2023 at Shahid Beheshti University. Kimiara presented Brelor (Ticagrelor), Leprenzo
Kimiara company participated in pain morning which was held on Monday 31th July of 2023 for a group of Tehran medical sciences University pain professors
Mofecon brand is a product of Concord Biotech Company, which is one of the most reliable companies producing immunosuppressive drugs. Quality and bioequivalence studies of Mofecon
Mofecon brand is a product of Concord Biotech Company, which is one of the most reliable companies producing immunosuppressive drugs. Quality and bioequivalence studies of
Kimiaara Pharmaceutical Company was established in 2005 as one of the subsidiaries of Ahran Tejarat Group.
Address : 2nd Floor, No. 27, Sharifi St., North Gandhi Ave., Tehran, Iran
All rights of this website belong to Kimiaara Pharmaceutical Company. © 2024
